NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
21.46
Dollar change
+0.22
Percentage change
1.04
%
IndexRUT P/E37.88 EPS (ttm)0.57 Insider Own8.47% Shs Outstand85.67M Perf Week0.00%
Market Cap1.84B Forward P/E25.33 EPS next Y0.85 Insider Trans-0.04% Shs Float78.46M Perf Month-2.37%
Enterprise Value1.61B PEG1.45 EPS next Q0.16 Inst Own88.20% Short Float8.44% Perf Quarter-6.61%
Income52.50M P/S1.52 EPS this Y-1.42% Inst Trans-7.43% Short Ratio5.85 Perf Half Y26.76%
Sales1.21B P/B3.94 EPS next Y50.75% ROA6.89% Short Interest6.63M Perf YTD24.41%
Book/sh5.45 P/C7.18 EPS next 5Y26.09% ROE10.11% 52W High30.42 -29.45% Perf Year-24.38%
Cash/sh2.99 P/FCF9.40 EPS past 3/5Y-4.58% - ROIC10.65% 52W Low13.39 60.27% Perf 3Y-27.82%
Dividend Est.- EV/EBITDA21.03 Sales past 3/5Y32.60% 38.42% Gross Margin21.99% Volatility3.76% 3.37% Perf 5Y-13.08%
Dividend TTM- EV/Sales1.33 EPS Y/Y TTM-7.81% Oper. Margin6.03% ATR (14)0.73 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.39 Sales Y/Y TTM9.47% Profit Margin4.33% RSI (14)49.04 Recom2.20
Dividend Gr. 3/5Y- - Current Ratio2.39 EPS Q/Q0.84% SMA20-0.19% Beta1.32 Target Price26.25
Payout0.00% Debt/Eq0.06 Sales Q/Q16.53% SMA50-1.81% Rel Volume0.53 Prev Close21.24
Employees680 LT Debt/Eq0.06 EarningsMay 08 AMC SMA2009.55% Avg Volume1.13M Price21.46
IPOOct 25, 2019 Option/ShortYes / Yes EPS/Sales Surpr.-10.71% 5.26% Trades Volume605,548 Change1.04%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Downgrade JP Morgan Overweight → Neutral $17
Nov-13-24Downgrade Truist Buy → Hold $26 → $19
Sep-19-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Aug-07-24Downgrade Leerink Partners Outperform → Market Perform $31 → $25
Aug-07-24Downgrade Canaccord Genuity Buy → Hold $37 → $24
Aug-07-24Downgrade BTIG Research Buy → Neutral
Jul-16-24Initiated JMP Securities Mkt Outperform $36
May-10-24Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-26-24Initiated Leerink Partners Outperform $49
Jan-03-24Initiated Barclays Overweight $48
Jun-30-25 08:55AM
Jun-26-25 12:33AM
Jun-24-25 02:07PM
10:42AM
10:40AM
09:10AM Loading…
09:10AM
08:54AM
07:56AM
07:31AM
04:41AM
Jun-10-25 09:02AM
May-29-25 09:03AM
May-20-25 12:01AM
May-18-25 11:35PM
May-14-25 09:05AM
03:58PM Loading…
May-12-25 03:58PM
May-09-25 11:46AM
03:44AM
May-08-25 06:55PM
05:55PM
04:14PM
11:40AM
09:25AM
May-07-25 05:35PM
01:10PM
May-06-25 01:09PM
07:11AM
May-05-25 02:48PM
07:25AM
May-01-25 10:01AM
02:49PM Loading…
Apr-24-25 02:49PM
Apr-21-25 12:10PM
Apr-17-25 09:36AM
Apr-16-25 08:58AM
Apr-08-25 08:57AM
Apr-07-25 05:08AM
Mar-31-25 09:22AM
Mar-18-25 05:03AM
Mar-17-25 05:01AM
Mar-13-25 05:03AM
Mar-11-25 09:03AM
Mar-07-25 02:00PM
Mar-05-25 04:01AM
Mar-03-25 04:03AM
Feb-28-25 07:34AM
02:39AM
Feb-27-25 04:49PM
04:11PM
04:01PM
Feb-26-25 08:01AM
07:35AM
Feb-20-25 10:25AM
10:00AM
Feb-13-25 03:14PM
Feb-03-25 12:00PM
Jan-29-25 12:10PM
08:50AM
Jan-28-25 08:44AM
Jan-16-25 09:00AM
Jan-13-25 08:00AM
08:00AM
Jan-03-25 03:00AM
Dec-27-24 09:02AM
Dec-18-24 08:33PM
Dec-11-24 10:38PM
Dec-02-24 01:38PM
Nov-29-24 09:59AM
Nov-18-24 09:08AM
Nov-14-24 09:00AM
06:45AM
Nov-13-24 04:40PM
02:19AM
Nov-12-24 05:35PM
04:30PM
04:02PM
Nov-11-24 07:10AM
Nov-08-24 09:20AM
Oct-29-24 02:00PM
Oct-21-24 08:12PM
Oct-14-24 11:17AM
Oct-10-24 01:58PM
Oct-07-24 11:45AM
Oct-05-24 04:23PM
Oct-02-24 12:42PM
Sep-30-24 02:41PM
Sep-23-24 03:41PM
02:00PM
Sep-19-24 04:17PM
02:46PM
02:15PM
11:37AM
11:30AM
10:53AM
09:12AM
Sep-06-24 06:43PM
Sep-03-24 02:26AM
Aug-23-24 08:46AM
Aug-07-24 01:48PM
12:26PM
Aug-06-24 08:00PM
Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm's network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scott CherylDirectorJun 11 '25Sale22.072,67559,03714,112Jun 12 05:07 PM
Scott CherylDirectorJun 11 '25Proposed Sale22.072,67559,039Jun 11 12:44 PM
Cohen Fred EFormer DirectorJun 03 '25Proposed Sale21.6862,2441,349,450Jun 03 12:05 PM
Schlanger David JExecutive ChairmanDec 26 '24Buy14.68150,0002,202,330228,269Dec 26 05:35 PM
Anevski PeterCHIEF EXECUTIVE OFFICERDec 23 '24Buy14.48209,5003,034,084441,463Dec 26 05:31 PM
SEIDENBERG BETH CDirectorDec 09 '24Proposed Sale15.8239,680627,648Dec 09 08:27 PM
Sturmer Michael EPRESIDENTJul 16 '24Sale30.009,030270,900362,583Jul 18 01:19 PM
Payson NormanDirectorNov 23 '24Sale56.2920011,258580,656Nov 26 04:34 PM